LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Regulation (EU) 2024/893 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Thermally treated garlic juice is approved as an active substance for use in biocidal products of product-type 19, subject to the conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Thermally treated garlic juice Thermally treated garlic juice EC No: — CAS No: — Thermally treated garlic juice is an unknown or variable composition, complex reaction products or of biological materials (UVCB) substance. The purity is 100 % weight per weight (w/w). It is derived from garlic juice that is thermally treated and has food grade quality. In addition, thermally treated garlic juice is characterised by four marker compounds: diallyl sulfide (DAS1), diallyl disulfide (DAS2), diallyl trisulfide (DAS3) and diallyl tetrasulfide (DAS4). 1 July 2025 30 June 2035 19 The authorisation of biocidal products is subject to the following condition:   the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/312 of 14 February 2025 amending Implementing Regulation (EU) 2018/2019 as regards certain plants for planting of Betula pendula and Betula pubescens, originating in the United KingdomCommission Implementing Regulation (EU) 2025/291 of 13 February 2025 imposing a provisional anti-dumping duty on imports of decor paper originating in the People’s Republic of ChinaCommission Implementing Regulation (EU) 2025/342 of 13 February 2025 on the registration of the geographical indication Caviar d’Aquitaine (PGI) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Delegated Regulation (EU) 2025/1190 of 13 February 2025 supplementing Regulation (EU) 2022/2554 of the European Parliament and of the Council with regard to regulatory technical standards specifying the criteria used for identifying financial entities required to perform threat-led penetration testing, the requirements and standards governing the use of internal testers, the requirements in relation to the scope, testing methodology and approach for each phase of the testing, results, closure and remediation stages and the type of supervisory and other relevant cooperation needed for the implementation of TLPT and for the facilitation of mutual recognitionCommission Implementing Regulation (EU) 2025/272 of 12 February 2025 concerning the renewal of the authorisation of L-cystine as a feed additive for all animal species and repealing Implementing Regulation (EU) No 1006/2013Commission Implementing Regulation (EU) 2025/273 of 12 February 2025 concerning the authorisation of a preparation of Lactiplantibacillus plantarum DSM 34271 as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2025/274 of 12 February 2025 laying down detailed rules for the application of Article 55 of Council Regulation (EC) No 1224/2009 on the control of recreational fisheriesCommission Implementing Regulation (EU) 2025/275 of 12 February 2025 concerning the renewal of the authorisation of a preparation of Saccharomyces cerevisiae CNCM I-4407 as a feed additive for rabbits other than suckling and breeding rabbits (holder of authorisation: S. I. Lesaffre) and repealing Implementing Regulation (EU) No 334/2012Commission Implementing Regulation (EU) 2025/276 of 12 February 2025 concerning the authorisation of clove tincture from Syzygium aromaticum (L.) Merr. & L.M. Perry as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2025/277 of 12 February 2025 concerning the authorisation of a preparation of Loigolactobacillus coryniformis DSM 34345 as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2025/278 of 12 February 2025 concerning the authorisation of cedarwood Texas essential oil from Juniperus deppeana Steud. as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2025/279 of 12 February 2025 concerning the authorisation of cajeput essential oil from Melaleuca cajuputi Maton & Sm. ex R. Powell and Melaleuca leucadendra (L.) L. as a feed additive for all animal species

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next